http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20284141

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 372
issn 1365-7852
1476-5608
issueIdentifier 3
pageRange 364-372
publicationName Prostate Cancer and Prostatic Diseases
startingPage 364
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5e4651ddb1e2085b46c23e16f1148a9b
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f44e02fcf9fa27484f2fa88838529c69
bibliographicCitation McKay RR, Montgomery B, Xie W, Zhang Z, Bubley GJ, Lin DW, Preston MA, Trinh Q, Chang P, Wagner AA, Mostaghel EA, Kantoff PW, Nelson PS, Kibel AS, Taplin M. Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockade. Prostate Cancer and Prostatic Diseases. 2017 Dec 20;21(3):364–72. doi: 10.1038/s41391-017-0009-6.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54bc82f605f15958a79aa26c28b80787
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_564f5b65e03b6143ce2f1564b7da6192
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5f85d801dcf389a6acae1e1fc4af2c6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d08bf03834d16555394b5f04e90c569f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9dd70973ef80f755918f7b511f4c3b32
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5e6f0e2f2d6020e3f1b9889c0d753f0f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d803c5374369c9f91d29e7d2278999e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3696aff5950861e5e99663a75993d7ab
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_521dacad9e57295eee3d1d1642580616
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2db4af099e8ddc828d935c5b9f7555e5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89853b7f15dd47ed76c5ad4a9599d7e6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_608a705a43b9a24c70b0cde794410168
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_408127993cf1d3f13fac770fd8082c5f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40df825619529e19b4f08715ae8fe517
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cd61cf5528ebe5b7a352bb8241b1c10
date 2017-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1038/s41391-017-0009-6
https://pubmed.ncbi.nlm.nih.gov/29263420
https://pubmed.ncbi.nlm.nih.gov/PMC6013399
isPartOf https://portal.issn.org/resource/ISSN/1365-7852
https://portal.issn.org/resource/ISSN/1476-5608
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30139
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockade
discusses http://id.nlm.nih.gov/mesh/M0026444
http://id.nlm.nih.gov/mesh/M0547064
http://id.nlm.nih.gov/mesh/M0011897
http://id.nlm.nih.gov/mesh/M0001103
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10251
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10309
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_831b83078073530f97985cd8e6573484
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983

Total number of triples: 49.